GenVec (GNVC) CEO Fischer to Step Down; Successor Named
Tweet
Share
E-mailGet Alerts GNVC Hot Sheet
Join SI Premium – FREE
GenVec, Inc. (Nasdaq: GNVC) announced that effective May 23, 2012 Cynthia Collins has been appointed as President and Chief Executive Officer. In addition, Ms. Collins is expected to be appointed to the Board of Directors of GenVec.
Effective upon Ms. Collins' appointment, Paul H. Fischer, Ph.D. will step down as GenVec's President and CEO and as a member of the Board. As announced in December, Dr. Fischer is retiring, having served as GenVec's President and CEO since 1996.
Collins previously served as Group Vice President, Cellular Analysis Business of Beckman Coulter from 2007 to until its sale in 2011.
Effective upon Ms. Collins' appointment, Paul H. Fischer, Ph.D. will step down as GenVec's President and CEO and as a member of the Board. As announced in December, Dr. Fischer is retiring, having served as GenVec's President and CEO since 1996.
Collins previously served as Group Vice President, Cellular Analysis Business of Beckman Coulter from 2007 to until its sale in 2011.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick board member to resign after CFO appointment at Best Buy
- Alto Neuroscience promotes Nick Smith to president and CFO
- Peabody Energy COO to shift to consulting role starting 2027
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
